Biovie Research Development from 2010 to 2026

BIVI Stock  USD 1.14  0.10  8.06%   
Biovie's Research Development is increasing with slightly volatile movements from year to year. Research Development is estimated to finish at about 20.1 M this year. For the period between 2010 and 2026, Biovie, Research Development quarterly trend regression had mean deviation of  18,044,753 and range of 133.2 M. View All Fundamentals
 
Research Development  
First Reported
2013-09-30
Previous Quarter
1.2 M
Current Value
2.9 M
Quarterly Volatility
19.5 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Biovie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biovie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 185.1 K, Other Operating Expenses of 22.9 M or Total Operating Expenses of 22.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0132 or PTB Ratio of 0.79. Biovie financial statements analysis is a perfect complement when working with Biovie Valuation or Volatility modules.
  
Build AI portfolio with Biovie Stock
Check out the analysis of Biovie Correlation against competitors.
The Research Development trend for Biovie Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Biovie is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Biovie's Research Development Growth Pattern

Below is the plot of the Research Development of Biovie Inc over the last few years. It is Biovie's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biovie's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Biovie Research Development Regression Statistics

Arithmetic Mean14,711,620
Geometric Mean976,506
Coefficient Of Variation218.98
Mean Deviation18,044,753
Median1,008,000
Standard Deviation32,215,734
Sample Variance1037.9T
Range133.2M
R-Value0.33
Mean Square Error987.3T
R-Squared0.11
Significance0.20
Slope2,098,589
Total Sum of Squares16605.7T

Biovie Research Development History

202620.1 M
202510.7 M
20249.3 M
202323.1 M
202233.3 M
202117.3 M
2020133.2 M

About Biovie Financial Statements

Investors use fundamental indicators, such as Biovie's Research Development, to determine how well the company is positioned to perform in the future. Although Biovie's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development10.7 M20.1 M

Currently Active Assets on Macroaxis

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
Check out the analysis of Biovie Correlation against competitors.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is there potential for Biotechnology market expansion? Will Biovie introduce new products? Factors like these will boost the valuation of Biovie. Projected growth potential of Biovie fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.12)
Return On Assets
(0.50)
Return On Equity
(0.95)
Understanding Biovie Inc requires distinguishing between market price and book value, where the latter reflects Biovie's accounting equity. The concept of intrinsic value—what Biovie's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Biovie's price substantially above or below its fundamental value.
It's important to distinguish between Biovie's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biovie should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biovie's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.